JALYN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Jalyn, and what generic alternatives are available?
Jalyn is a drug marketed by Woodward and is included in one NDA.
The generic ingredient in JALYN is dutasteride; tamsulosin hydrochloride. There are eighteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the dutasteride; tamsulosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Jalyn
A generic version of JALYN was approved as dutasteride; tamsulosin hydrochloride by ANCHEN PHARMS on February 26th, 2014.
Summary for JALYN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Patent Applications: | 11 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for JALYN |
What excipients (inactive ingredients) are in JALYN? | JALYN excipients list |
DailyMed Link: | JALYN at DailyMed |
Pharmacology for JALYN
Drug Class | 5-alpha Reductase Inhibitor alpha-Adrenergic Blocker |
Mechanism of Action | 5-alpha Reductase Inhibitors Adrenergic alpha-Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for JALYN
Paragraph IV (Patent) Challenges for JALYN
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
JALYN | Capsules | dutasteride; tamsulosin hydrochloride | 0.5 mg/0.4 mg | 022460 | 1 | 2010-10-26 |
US Patents and Regulatory Information for JALYN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Woodward | JALYN | dutasteride; tamsulosin hydrochloride | CAPSULE;ORAL | 022460-001 | Jun 14, 2010 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for JALYN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Woodward | JALYN | dutasteride; tamsulosin hydrochloride | CAPSULE;ORAL | 022460-001 | Jun 14, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
Woodward | JALYN | dutasteride; tamsulosin hydrochloride | CAPSULE;ORAL | 022460-001 | Jun 14, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
Woodward | JALYN | dutasteride; tamsulosin hydrochloride | CAPSULE;ORAL | 022460-001 | Jun 14, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for JALYN
See the table below for patents covering JALYN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Singapore | 52650 | Androstenone derivative | ⤷ Try a Trial |
Norway | 961080 | ⤷ Try a Trial | |
Cyprus | 2219 | Androstenone derivative | ⤷ Try a Trial |
Russian Federation | 2144037 | ANDROSTEN(ANE) (ONE) DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF, METHODS OF PREPARATION THEREOF, AND METHOD OF MEDICAL TREATMENT | ⤷ Try a Trial |
Finland | 961232 | ⤷ Try a Trial | |
Czech Republic | 9600745 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for JALYN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0719278 | C300122 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: DUTASTERIDUM, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR SOLVAAT; NAT. REGISTRATION NO/DATE: RVG 28317RVG 28318 2002161216; FIRST REGISTRATION: 1787117872 2002190719 |
0719278 | PA2003007 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: DUTASTERIDUM (17BETA-N(2,5-BIS(TRIFLUORMETIL)FENILKARBAMOIL-4-AZA-5ALFA-ANDROST-1-EN-3-ONAS), PASIRINKTINAI FARMACISKAI TINKAMO SOLVATO FORMOJE; REGISTRATION NO/DATE: 03/8183/7 20030909 |
0719278 | SPC/GB03/018 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: DUTASTERIDE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SOLVATE.; REGISTERED: SE 17871 20020719; SE 17872 20020719; UK PL 19494/0005 20030117; UK PL 19494/0006 20030117 |
0719278 | SPC009/2005 | Ireland | ⤷ Try a Trial | SPC009/2005: 20060316, EXPIRES: 20170718 |
0719278 | 23/2003 | Austria | ⤷ Try a Trial | PRODUCT NAME: DUTASTERIDE, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SOLVATES; NAT. REGISTRATION NO/DATE: 1-24844, 1-24845 20030217; FIRST REGISTRATION: SE 17871, 17872 20020719 |
0719278 | PA 2003 007, C 0719278 /L | Lithuania | ⤷ Try a Trial | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |